Evaluation of vitamin A supplement-therapy on immunologic profiles of pulmonary tuberculosis patient
S. Mohammadiam, S. M. Mirsaeidi, A. Ostad Rahimi, S. Shaghasempour, J. Baghdadchi, F. Mohammadi, M. Amiri, P. Tabarsi, S. D. Mansouri, M. R. Masjedi (Tabriz, Tehran, Islamic Republic Of Iran)
Source: Annual Congress 2005 - Biology of tuberculosis
Session: Biology of tuberculosis
Session type: Thematic Poster Session
Number: 4147
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Mohammadiam, S. M. Mirsaeidi, A. Ostad Rahimi, S. Shaghasempour, J. Baghdadchi, F. Mohammadi, M. Amiri, P. Tabarsi, S. D. Mansouri, M. R. Masjedi (Tabriz, Tehran, Islamic Republic Of Iran). Evaluation of vitamin A supplement-therapy on immunologic profiles of pulmonary tuberculosis patient. Eur Respir J 2005; 26: Suppl. 49, 4147
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Evaluation of vitamin A, E and C supplement therapy on immunologic profiles of pulmonary tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 455s Year: 2005
Evaluation of the effect of Category I anti tuberculous therapy on the vitamin D status of pulmonary tuberculosis patients Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019
Nutritional deficiency in patients with pulmonary tuberculosis Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis Year: 2021
Evaluating the nutritional status in active pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 427s Year: 2005
Clinical profile and outcome of complicated pulmonary tuberculosis in children Source: Eur Respir J 2002; 20: Suppl. 38, 362s Year: 2002
Nutritional status survey in pulmonary tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 689s Year: 2005
Clinical and morphological outcomes of pulmonary tuberculosis concurrent with chronic hepatitis Source: Eur Respir J 2006; 28: Suppl. 50, 13s Year: 2006
Clinical characteristics of paradoxical response to chemotheraphy in pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 520s Year: 2003
Iron status in pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 427s Year: 2005
Tuberculin hypersensitivity and its relation to nutritional status in patients with active pulmonary tuberculosis Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010
Biochemical portrait of patients with different course of pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 645s Year: 2004
The profile of patients with pulmonary and extrapulmonary tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 312s Year: 2001
Immunological criterions of the pulmonary tuberculosis progression Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008
Clinical effectiveness of steroid treatment on lung function and immunologic markers in pulmonary sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 86s Year: 2007
Vitamin C levels in Indian patients with active pulmonary tuberculosis Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010
Vitamin supplement-therapy and lipid hyper oxidation marker in pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 453s Year: 2005
Analysis of the pulmonary tuberculosis patients social status Source: Eur Respir J 2004; 24: Suppl. 48, 191s Year: 2004
Enhanced clinical improvement in pulmonary tuberculosis patients with antioxidant supplementation: a preliminary report Source: Eur Respir J 2003; 22: Suppl. 45, 40s Year: 2003
Evaluation of D-dimer levels in patients with active pulmonary tuberculosis and latent tuberculosis infection Source: Eur Respir J 2006; 28: Suppl. 50, 164s Year: 2006
Assessment of COVID-19 impact on the course of pulmonary tuberculosis Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities Year: 2021